Journal of Paediatric Medicine & Surgery
Open Access

Neonatal anemia refers to a condition in which a newborn baby has a lower than normal level of red blood cells or hemoglobin. Hemoglobin is crucial for carrying oxygen from the lungs to the rest of the body's tissues. Neonatal anemia can be caused by various factors, including:

Iron deficiency

Iron deficiency is a prevalent contributor to neonatal anemia, a condition where newborns have lower-than-normal levels of red blood cells or hemoglobin. The significance of iron in the development of healthy red blood cells makes it a critical factor in preventing anemia in infants. During pregnancy, maternal iron levels play a pivotal role in supporting the growing fetus. The developing baby relies on the mother's iron stores for its own blood cell production. In cases where the mother experiences insufficient iron intake or struggles with conditions that impede iron absorption, the newborn may not receive an adequate supply of iron during gestation [1]. Furthermore, the infant's own iron stores are essential in the early months of life, especially when transitioning from the womb to the external environment. If a newborn does not receive enough iron through breast milk or formula, or if the iron content in these sources is insufficient, it can lead to a deficiency and subsequent anemia.

Iron is a crucial component of hemoglobin, the protein responsible for transporting oxygen from the lungs to various tissues and organs. When iron levels are insufficient, the body struggles to produce an adequate amount of functional red blood cells, impairing the oxygencarrying capacity. This deficiency manifests in symptoms such as pale skin, lethargy, and poor feeding in the affected newborn. Addressing iron deficiency in neonates often involves supplementation with ironrich formulations, either as drops or in fortified formula. Expectant mothers are also encouraged to maintain adequate iron levels through a balanced diet or supplements as prescribed by healthcare professionals. Early detection and intervention are key in preventing complications and ensuring the optimal growth and development of the newborn. Regular monitoring and guidance from healthcare providers are essential to managing and overcoming iron deficiency-related neonatal anemia effectively.

Hemorrhage

Hemorrhage, or excessive bleeding, during delivery or in the immediate postnatal period is a significant factor contributing to neonatal anemia. This condition arises when the loss of blood exceeds the body's ability to regenerate red blood cells promptly. Hemorrhage in newborns can occur due to various factors, including complications during childbirth or specific medical conditions affecting the infant. Complications during childbirth, such as a difficult delivery, a prolonged labor process, or the need for instrumental assistance like forceps or vacuum extraction, may increase the risk of bleeding. Trauma or injury during birth can lead to internal or external bleeding, affecting the newborn's blood volume and, consequently, their hemoglobin levels [2].

Certain medical conditions or congenital anomalies in the newborn can also predispose them to hemorrhage. Disorders affecting blood clotting or the integrity of blood vessels may make the infant more susceptible to bleeding events. In some cases, the use of medications during pregnancy or labor may contribute to increased bleeding tendencies in the neonate. Prompt recognition and management of hemorrhage-related neonatal anemia are crucial to prevent complications. Healthcare professionals closely monitor infants for signs of anemia, including pallor, increased heart rate, and lethargy. Laboratory tests, such as a complete blood count (CBC), may be conducted to assess the severity of the anemia and guide appropriate interventions.

Treatment for neonatal anemia resulting from hemorrhage may involve blood transfusions to replenish the lost blood volume and restore adequate hemoglobin levels. In severe cases, additional measures to address the underlying cause of bleeding may be necessary, such as surgical interventions or medications to promote blood clotting. Preventive measures, including careful management of labor and delivery, thorough prenatal screenings, and monitoring of high-risk pregnancies, can help mitigate the risk of hemorrhage-related neonatal anemia. Collaborative efforts between healthcare providers and parents are essential in ensuring timely identification and effective treatment, fostering the optimal health and well-being of the newborn [3].

Inherited disorders

Inherited disorders represent a significant category of conditions that can contribute to neonatal anemia by influencing the production or function of red blood cells. These genetic conditions often involve mutations in the genes responsible for the synthesis of hemoglobin or the development of red blood cells, disrupting the normal processes essential for maintaining a healthy blood profile. One notable group of inherited disorders affecting red blood cells is the hemoglobinopathies, which include conditions like sickle cell anemia and thalassemia. In sickle cell anemia, a genetic mutation causes hemoglobin to form abnormal, crescent-shaped red blood cells. These misshapen cells can lead to blockages in blood vessels, impairing circulation and reducing the oxygen-carrying capacity of the blood. Thalassemia, on the other hand, involves mutations that result in inadequate production of hemoglobin, leading to anemia due to a deficiency in functional red blood cells.

Another example of an inherited disorder impacting red blood cells is hereditary spherocytosis. This condition involves a genetic mutation affecting the proteins in the red blood cell membrane, causing the cells to assume a spherical shape rather than their normal biconcave form. These abnormal cells are more prone to premature destruction in the spleen, leading to a reduced lifespan of red blood cells and subsequent anemia. In addition to hemoglobinopathies and membrane disorders, enzyme deficiencies can also be inherited, affecting the metabolic processes within red blood cells. For instance, glucose-6-phosphate dehydrogenase (G6PD) deficiency can result in hemolysis, where red blood cells break down more rapidly than usual, leading to anemia [4].

Diagnosing neonatal anemia caused by inherited disorders often involves genetic testing, which can identify specific mutations or abnormalities in the infant's DNA. Early detection is crucial for implementing appropriate management and intervention strategies. Treatment may involve supportive measures, such as blood transfusions to address anemia, or targeted therapies aimed at managing the underlying genetic condition. Genetic counseling plays a vital role in helping families understand the hereditary nature of these disorders and making informed decisions regarding family planning. Advances in medical research and genetic technologies continue to contribute to our understanding of these conditions, offering hope for improved diagnostics and treatment options in the future.

Premature birth

Premature birth, or preterm birth, significantly increases the risk of neonatal anemia due to the limited time that preterm infants have to accumulate sufficient iron stores during their fetal development period. Iron is a crucial element for the formation of hemoglobin, the protein responsible for oxygen transport in red blood cells. In full-term pregnancies, the third trimester is a critical period for iron accrual, but preterm infants may not benefit fully from this crucial developmental stage [5].

During the last trimester of pregnancy, the fetus accumulates iron from the mother, particularly during the final few weeks when iron transfer across the placenta is most efficient. In the case of premature birth, which occurs before 37 weeks of gestation, the infant is deprived of this essential period for iron accumulation. As a result, preterm infants are often born with lower iron stores than their full-term counterparts.

The immature organs and systems of preterm infants, including the gastrointestinal tract, may also hinder their ability to absorb iron effectively from breast milk or formula. Preterm infants often require specialized care, and their nutritional needs, including iron supplementation, must be carefully monitored and adjusted to support their growth and development. In addition to the risk of insufficient iron stores, preterm infants may face other challenges that contribute to neonatal anemia. The premature baby may experience medical complications such as respiratory distress syndrome, infections, or the need for blood transfusions, all of which can impact red blood cell production and increase the risk of anemia [6].

To mitigate the risk of neonatal anemia in preterm infants, healthcare providers often implement strategies such as early iron supplementation, tailored nutritional plans, and close monitoring of the baby's growth and blood parameters. Regular blood tests, including a complete blood count, help assess the infant's hemoglobin levels and guide appropriate interventions. Ensuring the optimal iron status and addressing anemia promptly are essential components of the comprehensive care provided to preterm infants. The collaborative efforts of healthcare professionals and parents play a crucial role in supporting the health and well-being of these vulnerable newborns as they navigate the challenges associated with premature birth.

Infections

Infections or illnesses in newborns can significantly impact the production and lifespan of red blood cells, contributing to neonatal anemia. The delicate and developing immune system of newborns makes them susceptible to various pathogens, and certain infections or illnesses can directly or indirectly affect the red blood cell count and function [7].

Direct effects on red blood cells: Some infections, such as bacterial or viral infections, can directly attack red blood cells, leading to their destruction or impairing their ability to function properly. This process, known as hemolysis, reduces the overall number of functional red blood cells and contributes to anemia. In severe cases, conditions like sepsis can lead to widespread inflammation and damage to red blood cells.

Inflammatory response: Infections trigger an inflammatory response in the body, and this inflammation can affect the production of red blood cells in the bone marrow. The balance between proinflammatory and anti-inflammatory cytokines can disrupt the normal erythropoiesis (red blood cell production) process, leading to anemia.

Nutritional deficiencies: Certain infections can interfere with the absorption and utilization of essential nutrients, including iron and vitamin B12, which are crucial for red blood cell production. Inadequate nutrition due to illness can result in a deficiency of these vital nutrients, further contributing to anemia [8].

Medication side effects: In some cases, medications used to treat infections or illnesses may have adverse effects on the bone marrow or red blood cell production. Chemotherapy or certain antibiotics, for example, can negatively impact the formation of red blood cells.

Chronic infections: Persistent or chronic infections can lead to ongoing inflammation and stress on the body, impacting the overall health of red blood cells. Conditions such as HIV or certain parasitic infections may have prolonged effects on the immune system and hematopoietic (blood-forming) tissues.

Prompt identification and treatment of infections in newborns are essential to prevent complications such as anemia. Healthcare providers may perform blood tests, including a complete blood count, to assess the red blood cell parameters and determine the severity of anemia. Treatment strategies may include antimicrobial therapy to combat the infection, supportive care to address nutritional deficiencies, and interventions to manage the inflammatory response [9,10].

Conclusion

Infections or illnesses in newborns can have diverse effects on red blood cells, ranging from direct destruction to indirect impacts on production and function. Early detection and comprehensive medical care are crucial in managing these conditions and minimizing the risk of neonatal anemia. The symptoms of neonatal anemia can include pale skin, lethargy, poor feeding, rapid breathing, and an increased heart rate. Diagnosing and treating neonatal anemia is crucial to prevent complications such as developmental delays and organ damage.

Treatment options may include iron supplementation, blood transfusions, or addressing the underlying cause of the anemia. Monitoring and managing neonatal anemia require close collaboration between healthcare professionals and parents to ensure the well-being and healthy development of the newborn. Regular check-ups, proper nutrition, and early intervention play vital roles in managing neonatal anemia effectively.

1. Gilmer T, Ojeda V, Folson D, Fuentes D, Garcia P, et al. (2007) Initiation and use of Public Mental Health Services by Persons with Severe Mental Illness and Limited English Proficiency. Psychiatric Services 58: 1555-1562.

Indexed at, Google Scholar, Crossref

2. Golding JM (1999) Intimate partner violence as a risk factor for mental disorders: A meta-analysis. JOFV 14: 99-132.

Indexed at, Google Scholar, Crossref

3. McHugo GJ, Kammerer N, Jackson EW, Markoff LS, Gatz M, et al. (2005) Women, Co-Occurring Disorders, and Violence Study: Evaluation Design and Study Population. J Subst Abuse Treat 28: 91-107.

Indexed at, Google Scholar, Crossref

4. Gary F (2005) Stigma: Barrier to Mental Health Care Among Ethnic Minorities. Issues Ment Health Nurs 26: 979-999.

Indexed at, Google Scholar, Crossref

5. Alhusen JL, Bullock L, Sharps P, Schminkey D, Comstock E, et al. (2014) Intimate partner violence during pregnancy and adverse neonatal outcomes in low-income women. J Women’s Health 23: 920-926.

Indexed at, Google Scholar, Crossref

6. Yoon JE, Lawrence E (2013) Psychological victimization as a risk factor in the developmental course of marriage. J Fam Psychol 27: 53-64.

Indexed at, Google Scholar, Crossref

7. Kastello JC, Jacobsen KH, Gaffney KF, Kodadek MP, Sharps PW, et al. (2016) Predictors of depression symptoms among low-income women exposed to perinatal intimate partner violence. Community Ment Health J 52: 683-690.

Indexed at, Google Scholar, Crossref

8. LeConte BA, Szaniszlo P, Fennewald SM, Lou DI, Qiu S, et al. (2018)Differences in the viral genome between HPV-positive cervical and oropharyngeal cancer 13: e0203403.

Indexed at, Google Scholar, Crossref

9. De Sanjosé S, Diaz M, Castellsagué X, Clifford G, Bruni L, et al.(2007)Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis.Lancet Infect Dis 7: 453-459.

Indexed at, Google Scholar, Crossref

10. Bruni L, Diaz M, Castellsagué X, Ferrer E, Bosch FX (2010)Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings.J Infect Dis 202: 1789-1799.

Indexed at, Google Scholar, Crossref